Editorial Governance
Clinical Review Board
Every entry in the Park Ave reference library is reviewed by a clinician or scientist in the relevant field. Reviews are repeated annually and after any major literature update.
Chair, Clinical Review Board
Marcus Chen, PharmD, BCPS
Pharmaceutical compounding · Analytical chemistry
Board-certified pharmacotherapy specialist with two decades in sterile compounding and quality systems. Oversees content accuracy and analytical reference standards across the library.
Endocrinology & Metabolic Review
Priya Kapoor, MD, FACE
Incretin pharmacology · GLP-1 / GIP / glucagon receptor biology
Endocrinologist focused on metabolic disease research. Reviews all incretin, GH-axis, and metabolic compound entries for clinical accuracy.
Regenerative & Tissue Repair Review
David Okonkwo, MD, PhD
Wound healing · Cytokine signaling · BPC / thymosin biology
Physician-scientist with published work in tissue repair and growth factor signaling. Reviews regenerative and immune-modulating peptide content.
Mitochondrial & Longevity Review
Elena Rossi, PhD
Mitochondrial bioenergetics · Cellular senescence
Translational researcher in mitochondrial medicine. Oversees content for SS-31, MOTS-c, NAD+, and longevity-adjacent compounds.
Quality Assurance & Documentation
Jordan Walker, PharmD
cGMP-aligned QA · COA and lot-release standards
Heads documentation review for purity, identity, and stability data. Validates every entry against the underlying analytical record.
Neuroscience & Behavioral Review
Sarah Nakamura, MD
Neuropeptide pharmacology · Cognitive and mood research
Reviews Selank, Semax, DSIP, and related neuropeptide entries. Active in clinical neuropsychiatry research.
Review Methodology
Every entry is sourced, drafted, peer-reviewed, and published according to a documented protocol. Read the full methodology for how this library is built and maintained.
View Methodology